MedPath

Acupuncture for Body Weight Control

Not Applicable
Completed
Conditions
Obesity
Registration Number
NCT02516878
Lead Sponsor
Hong Kong Baptist University
Brief Summary

In this study, a 18-week, single-blinded, randomized controlled clinical trial will be conducted to evaluate the effectiveness, efficacy and safety of acupuncture on weight control in Hong Kong.

Detailed Description

This is a pilot single-blind, randomized, sham-controlled trial. 72 participants will be randomly assigned to acupuncture group or control group. The duration of the treatment will be 8 weeks with 2 sessions per week and the follow-up period will be 8 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • aged between 18 and 65 years old;
  • body mass index (BMI)≥25 kg/m2;
  • having not received any other weight control measures or any medical and/or drug history within the last 3 months.
Exclusion Criteria
  • endocrine diseases;
  • heart diseases;
  • patients with pacemaker;
  • allergy and immunology diseases;
  • having bleeding tendency;
  • pregnant or lactating women;
  • having impaired hepatic or renal function;
  • stroke or otherwise unable to exercise.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in body weight during treatment and follow upThe change in body weight will be assessed every two weeks during 8-week treatment and 8-week follow up

measured by Omron KARADA Scan Body Composition \& Scale

Secondary Outcome Measures
NameTimeMethod
Change in body fat percentage during treatment and follow upThe change in body fat percentage will be assessed every two weeks during 8-week treatment and 8-week follow up

The change in body fat percentage will be measured by Omron KARADA Scan Body Composition \& Scale

Change in Body Mass Index (BMI) during treatment and follow upThe change in BMI will be assessed every two weeks during 8-week treatment and 8-week follow up

The change in Body Mass Index (BMI) will be measured by Omron KARADA Scan Body Composition \& Scale

Change in waist circumference during treatment and follow upThe change in waist circumference will be assessed every two weeks during 8-week treatment and 8-week follow up
Change in hip circumferenceThe change in hip circumference will be assessed every two weeks during 8-week treatment and 8-week follow up
Number of patients with adverse events after treatmentNumber of patients with adverse events after treatment will be recorded and compared among the two groups during 8-week treatment and 8-week follow up

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.